RightFit Trial Directory

Parkinson's Disease clinical trials in Phoenix, AZ

8 recruiting parkinson's disease studies with a site in Phoenix, AZ.

All trials in Phoenix, AZ · All Parkinson's Disease trials

RecruitingPhase 3NCT06170788

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

Sponsor: Merck Sharp & Dohme LLC

Phoenix, AZ · +14 more sites

RecruitingPhase 3NCT06966700

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

Sponsor: Merck Sharp & Dohme LLC

Gilbert, AZ · Phoenix, AZ · Tucson, AZ · +61 more sites

RecruitingPhase not listedNCT03664609

Deep Brain Stimulation (DBS) Retrospective Outcomes Study

Sponsor: Boston Scientific Corporation

Phoenix, AZ · +9 more sites

RecruitingPhase 3NCT07174310

A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease

Sponsor: Hoffmann-La Roche

Phoenix, AZ · +52 more sites

RecruitingPhase not listedNCT04994015

Parkinson's Foundation PD GENEration Genetic Registry

Sponsor: Parkinson's Foundation

Chandler, AZ · Phoenix, AZ · +61 more sites

RecruitingPhase not listedNCT07330258

A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications

Sponsor: Bayer

Phoenix, AZ · Tucson, AZ · +25 more sites

RecruitingPhase not listedNCT04477785

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Sponsor: Michael J. Fox Foundation for Parkinson's Research

Phoenix, AZ · Scottsdale, AZ · Sun City, AZ · +27 more sites

RecruitingPhase 4NCT06765668

A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

Sponsor: Impax Laboratories, LLC

Phoenix, AZ · +26 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.